Orchid Pharma Profile
Key Indicators
- Authorised Capital ₹ 150.00 Cr
as on 02-07-2024
- Paid Up Capital ₹ 50.72 Cr
as on 02-07-2024
- Company Age 32 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 224.00 Cr
as on 02-07-2024
- Satisfied Charges ₹ 15,353.51 Cr
as on 02-07-2024
- Revenue 21.09%
(FY 2023)
- Profit 1227.24%
(FY 2023)
- Ebitda 46.03%
(FY 2023)
- Net Worth 7.97%
(FY 2023)
- Total Assets 11.80%
(FY 2023)
About Orchid Pharma
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 524372 and on the National Stock Exchange(NSE) under BE : ORCHPHARMA.
The Corporate was formerly known as Orchid Chemicals & Pharmaceuticals Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 150.00 Cr and a paid-up capital of Rs 50.72 Cr.
The company currently has active open charges totaling ₹224.00 Cr. The company has closed loans amounting to ₹15,353.51 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Orchid Pharma Limited India are Sunil Gupta as CFO and Kapil Dayya as Company Secretary. Mridul Dhanuka, Manish Dhanuka, Arjun Dhanuka, and Five other members serve as directors at the Company.
- CIN/LLPIN
L24222TN1992PLC022994
- Company No.
022994
- Stock Symbol
BSE : 524372 NSE : BE : ORCHPHARMA
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
01 Jul 1992
- Date of AGM
09 Aug 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Listed
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Orchid Pharma?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manish Dhanuka  | Managing Director | 31-Mar-2020 | Current |
| Sunil Gupta | CFO | Current | |
| Kapil Dayya | Company Secretary | Current |
Board Members(7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Tanu Singla | Director | 29-Jun-2020 | Current |
| Mridul Dhanuka | Whole-Time Director | 31-Mar-2020 | Current |
| Manoj Goyal | Director | 29-Jun-2020 | Current |
| Arjun Dhanuka | Director | Current | |
| Ram Agarwal | Director | 31-Mar-2020 | Current |
| Mudit Tandon | Director | 29-Jun-2020 | Current |
Financial Performance and Corporate Structure Insights of Orchid Pharma.
Orchid Pharma Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 21.09% increase. The company also saw a substantial improvement in profitability, with a 1227.24% increase in profit. The company's net worth moved up by a moderate rise of 7.97%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Orchid Pharma?
In 2022, Orchid Pharma had a promoter holding of 89.96% and a public holding of 10.04%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
_PRIVATE_LIMITED.webp)
Dhanuka Laboratories LimitedActive 31 years 9 monthsMridul Dhanuka, Manish Dhanuka and 1 more are mutual person
_PRIVATE_LIMITED.webp)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Yes Bank Limited Creation Date: 27 Aug 2022 | ₹75.00 Cr | Open |
Hdfc Bank Limited Creation Date: 15 Nov 2021 | ₹149.00 Cr | Open |
Hdfc Bank Limited Creation Date: 02 Aug 2023 | ₹50.00 Cr | Satisfied |
How Many Employees Work at Orchid Pharma?
Orchid Pharma has a workforce of 928 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Orchid Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Orchid Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
